AR011669A1 - Un compuesto derivado de 5-aminoalcoxi-1,4-dihidroquinoxalin-2,3-dionas sustituidas, composicion farmaceutica, y el uso de los mismos para lafabricacion de un medicamento - Google Patents
Un compuesto derivado de 5-aminoalcoxi-1,4-dihidroquinoxalin-2,3-dionas sustituidas, composicion farmaceutica, y el uso de los mismos para lafabricacion de un medicamentoInfo
- Publication number
- AR011669A1 AR011669A1 ARP980100618A ARP980100618A AR011669A1 AR 011669 A1 AR011669 A1 AR 011669A1 AR P980100618 A ARP980100618 A AR P980100618A AR P980100618 A ARP980100618 A AR P980100618A AR 011669 A1 AR011669 A1 AR 011669A1
- Authority
- AR
- Argentina
- Prior art keywords
- manufacture
- pharmaceutical composition
- dihidroquinoxalin
- aminoalcoxi
- dionas
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80132497A | 1997-02-18 | 1997-02-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR011669A1 true AR011669A1 (es) | 2000-08-30 |
Family
ID=25180799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980100618A AR011669A1 (es) | 1997-02-18 | 1998-02-11 | Un compuesto derivado de 5-aminoalcoxi-1,4-dihidroquinoxalin-2,3-dionas sustituidas, composicion farmaceutica, y el uso de los mismos para lafabricacion de un medicamento |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0963372A1 (de) |
| JP (1) | JP2001511805A (de) |
| KR (1) | KR20000071162A (de) |
| CN (1) | CN1248249A (de) |
| AR (1) | AR011669A1 (de) |
| AU (1) | AU722616B2 (de) |
| BR (1) | BR9807230A (de) |
| CA (1) | CA2278757A1 (de) |
| HU (1) | HUP0001311A3 (de) |
| IL (1) | IL131160A0 (de) |
| NZ (1) | NZ336971A (de) |
| TW (1) | TW434230B (de) |
| WO (1) | WO1998035948A1 (de) |
| ZA (1) | ZA981306B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2285786B1 (de) | 2008-06-16 | 2013-10-09 | Merck Patent GmbH | Chinoxalindionderivate |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO179551C (no) * | 1987-11-10 | 1996-10-30 | Novo Nordisk As | Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser |
| DK715888D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Quinoxalinforbindelser, deres fremstilling og anvendelse |
| US4975430A (en) * | 1989-06-16 | 1990-12-04 | The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University | CNQX and its analogs as therapeutics for degenerative neural diseases |
| PT99864B (pt) * | 1990-12-21 | 1999-06-30 | Schering Ag | Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato |
| US5159083A (en) * | 1990-12-28 | 1992-10-27 | Neurogen Corporation | Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands |
| ES2313714T3 (es) * | 1992-06-22 | 2009-03-01 | The Regents Of The University Of California | Antagonistas de receptores de glicina y uso de los mismos. |
| GB9419318D0 (en) * | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
| DK0707007T3 (da) * | 1994-10-14 | 2002-03-18 | Merck Patent Gmbh | Amino(thio)etherderivater som CNS-aktive midler |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
-
1998
- 1998-01-13 CN CN98802636A patent/CN1248249A/zh active Pending
- 1998-01-13 HU HU0001311A patent/HUP0001311A3/hu unknown
- 1998-01-13 BR BR9807230-7A patent/BR9807230A/pt not_active Application Discontinuation
- 1998-01-13 KR KR1019997007452A patent/KR20000071162A/ko not_active Application Discontinuation
- 1998-01-13 IL IL13116098A patent/IL131160A0/xx unknown
- 1998-01-13 AU AU60350/98A patent/AU722616B2/en not_active Ceased
- 1998-01-13 WO PCT/US1998/001170 patent/WO1998035948A1/en not_active Application Discontinuation
- 1998-01-13 CA CA002278757A patent/CA2278757A1/en not_active Abandoned
- 1998-01-13 NZ NZ336971A patent/NZ336971A/xx unknown
- 1998-01-13 JP JP53574298A patent/JP2001511805A/ja active Pending
- 1998-01-13 EP EP98903628A patent/EP0963372A1/de not_active Withdrawn
- 1998-02-05 TW TW087101493A patent/TW434230B/zh active
- 1998-02-11 AR ARP980100618A patent/AR011669A1/es unknown
- 1998-02-17 ZA ZA9801306A patent/ZA981306B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU722616B2 (en) | 2000-08-10 |
| CA2278757A1 (en) | 1998-08-20 |
| HUP0001311A2 (hu) | 2001-05-28 |
| WO1998035948A1 (en) | 1998-08-20 |
| IL131160A0 (en) | 2001-01-28 |
| AU6035098A (en) | 1998-09-08 |
| EP0963372A1 (de) | 1999-12-15 |
| JP2001511805A (ja) | 2001-08-14 |
| BR9807230A (pt) | 2000-04-25 |
| ZA981306B (en) | 1999-08-17 |
| CN1248249A (zh) | 2000-03-22 |
| HUP0001311A3 (en) | 2001-07-30 |
| NZ336971A (en) | 2000-10-27 |
| KR20000071162A (ko) | 2000-11-25 |
| TW434230B (en) | 2001-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR029766A1 (es) | Compuesto inhibidor de quinasa y uso del mismo para preparar una composicion farmaceutica | |
| SE0104334D0 (sv) | Therapeutic agents | |
| EA200200571A1 (ru) | Новая композиция и ее применение | |
| EA200300323A1 (ru) | ПРОИЗВОДНЫЕ ГУАНИДИНОБЕНЗАМИДА (ВАРИАНТЫ), КОМПОЗИЦИЯ (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ ОПОСРЕДОВАННОГО mc4-r ЗАБОЛЕВАНИЯ (ВАРИАНТЫ) | |
| SE9504661D0 (sv) | New compounds | |
| ATE445597T1 (de) | ß2-OXO-1-PYRROLIDINDERIVATE UND IHRE PHARMAZEUTISCHE VERWENDUNGß | |
| PA8495101A1 (es) | Derivados de 13-metileritromicina | |
| AR024998A1 (es) | Nuevos retinoides para el tratamiento del enfisema | |
| DE69231298D1 (de) | Substituierte Dibenzoxazepinverbindungen, pharmazeutische Zusammensetzungen und Anwendungsmethoden | |
| SE9903997D0 (sv) | New compounds | |
| SE0300908D0 (sv) | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | |
| AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
| AR024840A1 (es) | Compuestos de 5ht1 para terapia antidepresiva; composiciones farmaceuticas y su uso en la preparacion de medicamentos. | |
| AR010899A1 (es) | Oxazolidinonas, un procedimiento para su preparacion, el empleo de las mismas para preparar un medicamento, medicamentos y preparaciones farmaceuticasque las contienen y un procedimiento para obtener estas preparaciones farmaceuticas. | |
| AR025351A1 (es) | Agonistas retinoides selectivos par | |
| AR035006A1 (es) | Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento. | |
| PT99864A (pt) | Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato | |
| CO4410322A1 (es) | Nuevos compuestos de carboxamida, sus sales farmaceuticamente aceptables y composiciones farmaceuticas que los contienen | |
| AR013241A1 (es) | Derivados del acido aminoetilfenoxiacetico, composicion farmaceutica que incluye a dicho derivado, medicamento para reducir el dolor y promover la eliminacion de calculos en urolitiasis, utilizacion de dicho derivado para la fabricacion de dicha composicion farmaceutica y procedimiento para la fabri | |
| AR011669A1 (es) | Un compuesto derivado de 5-aminoalcoxi-1,4-dihidroquinoxalin-2,3-dionas sustituidas, composicion farmaceutica, y el uso de los mismos para lafabricacion de un medicamento | |
| UY27324A1 (es) | Nuevas sales de napsilato i | |
| BR9406897A (pt) | Compostos de tetraidroisoquinolina composiçoes farmaceuticas processo de analgesia ou de tratamento de psicoses doença de parkinson sindrome de leschnyan distúrbio da falta de atençao ou danos cognitivos ou na supressao da dependencia de drogas ou discinesia tardia e uso de um composto | |
| KR930010016A (ko) | 단백질 분해효소 억제제인 사카린 유도체 | |
| KR900014397A (ko) | 티에노-트리아졸로-디아제핀 술포닐 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물 | |
| AR020773A1 (es) | Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto |